11/12/2024Wuxi iCampus Partners with Hong Kong COCHE and AstraZeneca for Cardiov...

11/12/2024Trump Presidency to Test Public Trust in Big Pharma (SWI)

11/11/2024China Biopharma Tracker – October 2024 (PharmaDJ)

11/11/2024Trump's Trade Tango Returns: Will China's Biotech Dance Through Anothe...

11/11/2024China Biotech and the Bear: A Perspective (BioCentury)

11/11/2024Alphamab Reports Results of FIH Clinical Study of Anti-HER2 ADC and PD...

11/11/2024NHSA and MOF Jointly Issue the Notice on Prepayment of BMI Funds

11/11/2024China to Launch Pilot Programme for Virtual Primary Care Standards

11/8/2024Junshi Reports on Phase II Trial of Toripalimab in Combo with Gemcitab...

11/8/2024Pfizer Ignite Partners with Beijing Mabworks to Develop Novel MM Thera...

11/8/2024Ping An Health and Medtronic Form Strategic Partnership at the CIIE

11/8/2024Recent Executive Moves

11/7/2024A Share-Listed Pharma Companies Report Solid Performance in Q3/2024

11/7/2024Minghui Pharma Announces Promising Initial Results from Phase I Trial ...

11/7/2024Aditum Bio and Leads Biolabs Forms JV Oblenio Bio to Develop a Tri-Spe...

11/7/2024Stimulus Package vs. Drug Price Negotiation, Impacts on China's Health...

11/6/2024NMPA Accepts AbbVie's BLA for Epcoritamab (Epkinly) for Lymphomas

11/6/2024Pharma Firms Present Innovative Treatments for Major Diseases at CIIE

11/6/2024MNCs and Chinese Partners Join Forces to Build an Innovative Healthcar...

11/5/2024NMPA Solicits Public Comments on Drug Contract Manufacturing Document

11/5/2024AstraZeneca China Updates Leadership and Ownership Structure Amid Inve...

11/5/2024Huadong Medicine's Ustekinumab Biosimilar HDM3001 Receives Approval

11/5/2024Photocure's Hexvix Secures Approval in China for Bladder Cancer Diagno...

11/5/2024Landmark Whistleblower Program for China's Healthcare Sector: Proposed...

11/4/2024Probe of AstraZeneca Executive in China Raises Questions about Company...

11/4/2024How AstraZeneca Bilked China's Insurance Program Out of CNY Millions (...

11/4/2024Big Pharma Doubles Down on China (The Wire China)

11/4/2024HuidaGene Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Ed...

11/4/2024US FDA Accepts BLA for HLX14, Biosimilar Candidate of PROLIA/XGEVA

11/4/2024China Targets AstraZeneca in BMI Fraud Probe over Tagrisso

Page:19/359 Total number of articles:10751: [First][<<] [17] [18] [19] [20] [21] [>>] [End]